中华耳鼻咽喉头颈外科杂志
中華耳鼻嚥喉頭頸外科雜誌
중화이비인후두경외과잡지
CHINESE JOURNAL OF OTORHINOLARYNGOLOGY HEAD AND NECK SURGERY
2011年
12期
1033-1035
,共3页
钱国红%赏金标%王可敬%谭卓
錢國紅%賞金標%王可敬%譚卓
전국홍%상금표%왕가경%담탁
癌,神经内分泌%鼻窦肿瘤%综合疗法%预后
癌,神經內分泌%鼻竇腫瘤%綜閤療法%預後
암,신경내분비%비두종류%종합요법%예후
Carcinoma,neuroendocrine%Paranasal sinus neoplasms%Combined moddity therapy%Prognosis
目的 探讨鼻腔鼻窦神经内分泌癌的诊疗方法及预后.方法 回顾性分析浙江省肿瘤医院1998-2010年收治的11例鼻腔鼻窦神经内分泌癌患者的临床资料.其中小细胞神经内分泌癌10例,非典型类癌1例.参照Kadish分期本组患者A期2例,B期6例,C期3例.治疗方法采取单纯手术1例,单纯放疗1例,单纯化疗1例,放疗+化疗2例,以手术为主的综合治疗(手术结合术后放化疗)6例.结果 全部患者随访2个月至12年,综合治疗的6例中1例3年后死亡,1例4年后死亡,1例无瘤生存12年,另2例无瘤生存8年,1例仍在治疗随访中.其他治疗方案的5例中4例1年内死亡,1例1年半后死亡.结论 本病治疗并无统一方案,以手术为主的综合性治疗是较合适的治疗方案.神经内分泌癌易复发,预后较差,早期的准确诊断和综合治疗是提高本病生存率的关键.
目的 探討鼻腔鼻竇神經內分泌癌的診療方法及預後.方法 迴顧性分析浙江省腫瘤醫院1998-2010年收治的11例鼻腔鼻竇神經內分泌癌患者的臨床資料.其中小細胞神經內分泌癌10例,非典型類癌1例.參照Kadish分期本組患者A期2例,B期6例,C期3例.治療方法採取單純手術1例,單純放療1例,單純化療1例,放療+化療2例,以手術為主的綜閤治療(手術結閤術後放化療)6例.結果 全部患者隨訪2箇月至12年,綜閤治療的6例中1例3年後死亡,1例4年後死亡,1例無瘤生存12年,另2例無瘤生存8年,1例仍在治療隨訪中.其他治療方案的5例中4例1年內死亡,1例1年半後死亡.結論 本病治療併無統一方案,以手術為主的綜閤性治療是較閤適的治療方案.神經內分泌癌易複髮,預後較差,早期的準確診斷和綜閤治療是提高本病生存率的關鍵.
목적 탐토비강비두신경내분비암적진료방법급예후.방법 회고성분석절강성종류의원1998-2010년수치적11례비강비두신경내분비암환자적림상자료.기중소세포신경내분비암10례,비전형유암1례.삼조Kadish분기본조환자A기2례,B기6례,C기3례.치료방법채취단순수술1례,단순방료1례,단순화료1례,방료+화료2례,이수술위주적종합치료(수술결합술후방화료)6례.결과 전부환자수방2개월지12년,종합치료적6례중1례3년후사망,1례4년후사망,1례무류생존12년,령2례무류생존8년,1례잉재치료수방중.기타치료방안적5례중4례1년내사망,1례1년반후사망.결론 본병치료병무통일방안,이수술위주적종합성치료시교합괄적치료방안.신경내분비암역복발,예후교차,조기적준학진단화종합치료시제고본병생존솔적관건.
Objective To study the diagnosis,treatment and prognosis of sinonasal neuroendocrine carcinoma.Methods The clinical data of 11 cases with sinonasal neuroendocrine carcinoma treated in Zhejiang Cancer Hospital from 1998 to 2010 were analyzed retrospectively.Ten cases were small cell type and one case was atypical carcinoid.Two cases were Kadish stage A,six cases were Kadish stage B and three cases were Kadish stage C.One case was treated by only operation,one case by only radiotherapy,one case by only chemotherapy,two cases by radiotherapy and chemotherapy,and six cases by combined treatment(surgery followed by radiotherapy and chemotherapy).Results All cases were followed up for 2 months up to 12 years.Of six cases by combined treatment two cases died in 3 years and in 4 years after treatment respectively,three cases survived tumor-free for 12,8 and 8 years and one case was still in treatment.Of other five cases,four cases died in 12 months and one case died in 18 months after treatment.Conclusions There's no standard treatment plan.Combined treatment based on surgery should be adopted to nasal neuroendocrine carcinoma.Recurrence is common and the prognosis is poor.The key to improving the survival rate of the disease is early accurate diagnosis and combined treatment.